News
News
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
Clearmind Medicine Inc. announced the initiation of clinical batches of production of its novel psychedelic-derived drug candidate, the MEAI- based...
Read moreDetails
SKYX Approved by American Institute of Architects (AIA) for Inclusion in its Annual Continuing Education Systems Course for Architects
SKYX Platforms Corp announced that the American Institute of Architects (“AIA”) has included a SKYX course as part of architects...
Read moreDetails
AgriFORCE Receives Notice of Allowance Related to its FORCEGH+ Facility from the United States Patent and Trademark Office
November 17, 2022 – AgriFORCE Growing Systems Ltd. today announced it has received a Notice of Allowance from the United...
Read moreDetails
American Rebel Reports Financial Results for 2022 Third Quarter Champion Acquisition Drives Quarterly Revenue to $4.1 Million
Nashville, TN / November 15, 2022 / GLOBE NEWSWIRE / -- American Rebel Holdings, Inc. (NASDAQ: AREB) – America’s Patriotic...
Read moreDetails
SUNSHINE BIOPHARMA ENTERS INTO A COLLABORATION AGREEMENT WITH A LEADING LIPID NANOPARTICLE FORMULATION COMPANY FOR ITS K1.1 ANTICANCER mRNA PROJECT
Sunshine Biopharma Inc. today announced that it has entered into a collaboration agreement with one of North America’s leading lipid...
Read moreDetails
SinglePoint Inc. Reports Record Revenue in Third Quarter 2022 Achieves 24 Fold Increase Over Q3 2021
SinglePoint Inc. announced its Third Quarter 2022 financial results today. SinglePoint Inc. credits its acquisition strategy for delivering significant revenue...
Read moreDetails
Organicell Activates COPD Trial at Mayo Clinic
DAVIE, FL / ACCESSWIRE / November 15, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), is pleased to announce that...
Read moreDetailsSKYX to Host Virtual Investor Event to Discuss New Developments on Thursday, November 17, at 11:00am Eastern
SKYX Platforms Corp. today announced that it will host a virtual investor event on Thursday, November 17, 2022, at 11:00am...
Read moreDetails
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”), announced today a new partnership focused on developing and...
Read moreDetails
Jupiter Wellness Re-Opens Enrollment in Clinical Trial Comparison of JW-100 and EUCRISA for the Treatment of Eczema
Jupiter Wellness, Inc. (Nasdaq:JUPW), announced today that it has re-opened enrollment in a clinical trial aimed at evaluating the superiority...
Read moreDetails